サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1622105

骨盤臓器脱用デバイスの世界市場規模：デバイス別、用途別、エンドユーザー別、地域別、範囲および予測

Global Pelvic Organ Prolapse Devices Market Size By Device (Vaginal Pessary, Vaginal Mesh), By Application (Surgical Devices, Non-Surgical Devices), By End-User (Hospitals, Ambulatory Surgical Centers), By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
骨盤臓器脱用デバイスの世界市場規模：デバイス別、用途別、エンドユーザー別、地域別、範囲および予測
出版日: 2024年07月02日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

骨盤臓器脱用デバイスの市場規模と予測

骨盤臓器脱用デバイス市場規模は、2022年に1億8,536万米ドルと評価され、2023年から2030年にかけてCAGR 4.12%で成長し、2030年には4億512万米ドルに達すると予測されます。世界の老人人口の増加と、高齢化した女性人口におけるPOP有病率の上昇が、予測される年月にわたって骨盤臓器脱用デバイス市場を牽引すると期待されています。骨盤臓器脱用デバイスの世界市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

骨盤臓器脱用デバイスの世界市場定義

骨盤臓器脱は、骨盤領域の支持組織や筋肉が弱くなったり緩んだりした後に発生する疾患です。この疾患は治療可能であるが、骨盤臓器脱用デバイスは、膀胱、子宮、小腸、膣の一部を含む骨盤内臓器をサポートするためのものです。

膀胱脱は膀胱瘤として知られています。一方、小腸の脱出は腸瘻と呼ばれます。直腸脱は直腸瘤と呼ばれます。骨盤臓器脱用の器具としては、膣ペッサリーと膣メッシュがあります。これらの器具は、外科用器具や非外科用器具などの用途に使用されます。骨盤臓器脱用器具のエンドユーザーは病院、外来手術センター、その他です。

骨盤臓器脱用デバイスの世界市場概要

世界の高齢者人口の増加と、高齢化した女性人口におけるPOP有病率の上昇が、予測される年数にわたって骨盤臓器脱用デバイス市場を牽引すると期待されています。これに加えて、ヘルスケア支出の伸びは過去数十年にわたって急激な伸びを示しており、予測期間中も同様の傾向を示すと予想されます。このことは、今後数年間の骨盤臓器脱装置の採用をさらに補完するものと思われます。世界保健機関（WHO）が発表したデータによると、骨盤臓器脱は60～69歳の女性に最も多く見られる疾患の1つです。POP患者の約37％は60～70歳で、半数以上は80歳以上です。

これに加えて、骨盤臓器脱修復治療における技術的進歩や研究開発の進行、女性の健康に対する意識の高まりが、今後数年間で市場を押し上げると予想されます。しかし、市場成長の妨げとなる一定の抑制要因や課題も存在します。科学的な有効性と安全性の欠如、手術にかかるコストの高さ、複雑な規制規範や基準などの要因は、需要をある程度制限します。

目次

第1章 骨盤臓器脱用デバイスの世界市場：イントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次インタビュー
  • データソース一覧

第4章 骨盤臓器脱用デバイスの世界市場展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 骨盤臓器脱用デバイスの世界市場：デバイス別

  • 概要
  • 膣ペッサリー
  • 膣メッシュ

第6章 骨盤臓器脱用デバイスの世界市場：用途別

  • 概要
  • 手術用デバイス
  • 非手術用デバイス

第7章 骨盤臓器脱用デバイスの世界市場：エンドユーザー別

  • 概要
  • 病院
  • 外来手術センター
  • その他

第8章 骨盤臓器脱用デバイスの世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • その他のラテンアメリカ
  • 中東・アフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 骨盤臓器脱用デバイスの世界市場：競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な発展戦略

第10章 企業プロファイル

  • Johnson & Johnson Services, Inc.
  • Coloplast Pty Ltd
  • Boston Scientific Corporation
  • CooperSurgical, Inc.
  • Dr. Arabin GmbH & Co. KG
  • Integra LifeSciences
  • Utah Medical Products, Inc.
  • Tic Med
  • Cleo
  • Shenzhen XFT Medical Limited
  • Sunmedix Co, Ltd.
  • Verity Medical Ltd
  • Neomedic
  • Medtronic

第11章 企業プロファイル主な発展

  • 製品上市／開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第12章 付録

  • 関連調査
目次
Product Code: 15371

Pelvic Organ Prolapse Devices Market Size And Forecast

Pelvic Organ Prolapse Devices Market size was valued at USD 185.36 Million in 2022 and is projected to reach USD 405.12 Million By 2030 , growing at a CAGR of 4.12% from 2023 to 2030. The increasing global geriatric population and rising prevalence of POP in the aging female population are expected to drive the Pelvic Organ Prolapse Devices Market over the predicted years. The Global Pelvic Organ Prolapse Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Pelvic Organ Prolapse Devices Market Definition

Pelvic organ prolapse is a condition that occurs after the supporting tissues and muscles become weak or loose in the pelvic region. Though the disease is treatable, pelvic organ prolapse devices are meant to provide support to the pelvic organs including the bladder, uterus, small intestine, and part of the vagina.

The prolapse of the bladder is known as a cystocele. While prolapse of the small bowel is known as enterocele. If there's a prolapse of the rectum, it is known as a rectocele. The devices for pelvic organ prolapse are vaginal pessary and vaginal mesh. They are used in applications including Surgical Devices and Non-Surgical Devices. End-users of pelvic organ prolapse devices are Hospitals, Ambulatory Surgical Centers, and Others.

Global Pelvic Organ Prolapse Devices Market Overview

The increasing global geriatric population and rising prevalence of POP in the aging female population are expected to drive the Pelvic Organ Prolapse Devices Market over the predicted years. Besides this, the healthcare expenditure growth has witnessed exponential growth over the past couple of decades and it is expected to show the similar trend over the forecasted period. This will further complement the adoption of pelvic organ prolapse devices over the upcoming years. As per the data published by the World Health Organization, Pelvic organ prolapse is one of the most common in disease found across the women aged 60 to 69. Around 37% of the POP patients are between 60-70 years of age and more than half of the patients are more than 80 years of age.

In addition to this, technical advancements and ngoing research and developments in pelvic organ prolapse repair treatments and the growing awareness about women's health expect a boost to the market in the coming years.The ongoing investments and frequent need for the respective treatments will create substantial opportunities over the forecasted period. However, there are certain restraints and challenges faced which can hinder market growth. Factors such as lack of scientific efficacy & safety, higher costs involved in surgeries, and complex regulatory norms and standards will restrict the demand to some extent.

Global Pelvic Organ Prolapse Devices Market: Segmentation Analysis

The Global Pelvic Organ Prolapse Devices Market is Segmented on the basis of Device, Application, End-User, and Geography.

Pelvic Organ Prolapse Devices Market, By Device

  • Vaginal Pessary
  • Vaginal Mesh

Based on Device, the market is bifurcated into Vaginal Pessary and Vaginal Mesh. The Vaginal Pessary segment is expected to hold the largest market share. The factors can be attributed to a higher preference for vaginal pessary as vaginal mesh causes bleeding which are one of the most commonly found instances wherein the pelvic organ prolapse devices are generally used.

Pelvic Organ Prolapse Devices Market, By Application

  • Surgical Devices
  • Non-Surgical Devices

Based on Application, the market is bifurcated into Surgical Devices and Non-Surgical Devices. Surgical Devices are predicted to hold the most significant CAGR in the forecasted period as surgical devices are more effective than non-surgical devices in the treatment of pelvic organ prolapse. On the other hand, non surgical devices will also significant share considering the varying needs in line with the symptoms and medication instances.

Pelvic Organ Prolapse Devices Market, By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Based on End-User, the market is bifurcated into Hospitals, Ambulatory Surgical Centers, and Others. Hospitals are anticipated to hold the largest market share. These factors can be credited to the higher rate of surgeries, growing treatment instances in the hospitals and lack of device applications in other clinics and ambulatory surgical centers. However, the ambulatory surgical centers will grow at the significant rate considering the rising awareness and ease of access.

Pelvic Organ Prolapse Devices Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America
  • On the basis of regional analysis, the GlobalPelvic Organ Prolapse Devices Market is classified into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America led the Global Pelvic Organ Prolapse Devices Market in terms of growth, accounting for a sizable market share. The region is technologically advanced, and it was an early adoption of advanced healthcare technologies. Besides this, the strengthened healthcare infrastructure will further complement the market growth.

Key Players

  • The "Global Pelvic Organ Prolapse Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Johnson & Johnson Services, Inc., Coloplast Pty Ltd, Boston Scientific Corporation, CooperSurgical, Inc., Dr. Arabin GmbH & Co. KG, Integra LifeSciences, , Utah Medical Products, Inc., Tic Med, Cleo, Shenzhen XFT Medical Limited, Sunmedix Co, Ltd., Verity Medical Ltd, Neomedic, and Medtronic among others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In March 2020, the pelvic organ prolapse devices manufacturers, Fotofinder Zsystems Inc. has rebranded automated total body mapping systems as total body dermoscopy, allowing for immediate evaluation of dermoscopic structures of oles on full body photos.
  • Ace Matrix Analysis
  • The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
  • Active, Cutting Edge, Emerging, and Innovators.
  • Market Attractiveness
  • The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Pelvic Organ Prolapse Devices market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
  • Porter's Five Forces
  • The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. The porter's five forces model can be used to assess the competitive landscape in global Pelvic Organ Prolapse Devices market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET, BY DEVICE

  • 5.1 Overview
  • 5.2 Vaginal Pessary
  • 5.3 Vaginal Mesh

6 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Surgical Devices
  • 6.3 Non-Surgical Devices

7 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Others

8 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Rest of LATAM
  • 8.6 Middle East and Africa
    • 8.6.1 UAE
    • 8.6.2 Saudi Arabia
    • 8.6.3 South Africa
    • 8.6.4 Rest of the Middle East and Africa

9 GLOBAL PELVIC ORGAN PROLAPSE DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Johnson & Johnson Services, Inc.
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Coloplast Pty Ltd
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Boston Scientific Corporation
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 CooperSurgical, Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Dr. Arabin GmbH & Co. KG
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Integra LifeSciences
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Utah Medical Products, Inc.
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Tic Med
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Cleo
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Shenzhen XFT Medical Limited
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments
  • 10.11 Sunmedix Co, Ltd.
    • 10.11.1 Overview
    • 10.11.2 Financial Performance
    • 10.11.3 Product Outlook
    • 10.11.4 Key Developments
  • 10.12 Verity Medical Ltd
    • 10.12.1 Overview
    • 10.12.2 Financial Performance
    • 10.12.3 Product Outlook
    • 10.12.4 Key Developments
  • 10.13 Neomedic
    • 10.13.1 Overview
    • 10.13.2 Financial Performance
    • 10.13.3 Product Outlook
    • 10.13.4 Key Developments
  • 10.14 Medtronic
    • 10.14.1 Overview
    • 10.14.2 Financial Performance
    • 10.14.3 Product Outlook
    • 10.14.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research